Establishing a skills pipeline remains crucial for the pharmaceutical industry and we have been proactive about STEM skills and employability, helping students from a diverse range of backgrounds to make informed choices about fulfilling careers in a highly productive sector of the economy.
We have also been clear about the need for the UK to develop a future immigration system that is needs-based, straightforward and rapid, and which facilitates the ease of movement for highly skilled talent in life sciences.
For us, it’s not just about staying globally competitive today but about being ready for the future. The UK must be ready to plug evolving skills gaps to maintain its world-leading position for medicines and vaccines research and development.
In 2019 we identified major skills gaps in areas including genomics, immunology, bioinformatics, chemoinformatics, and clinical pharmacology – emerging areas of technology that mark the frontier of medical innovation.
There are more than 31,000 more jobs that need to be filled by 2025 in highly skilled scientific roles vital to the UK’s successful pharmaceutical and biotech sectors. This needs to be addressed for our industry to thrive and continue to be a key strength to the UK economy.
As part of our commitment to assisting the development of a skills pipeline, the ABPI has taken a cross-sector approach forming the ‘Clinical Pharmacology Skills Alliance’ to represent the interests of the pharmaceutical industry, and the clinical pharmacologists who are working across industry, academia and the NHS.
In the Life Science Industrial Strategy Sector Deal 2, the pharmaceutical industry made a commitment to work with Government to:
We are working with partners throughout the wider life sciences ecosystem to make sure the UK is ready to make the most of emerging technologies and realise our ambition to make it the best place in the world to research, develop and use new medicines and vaccines.
Science research is a global endeavour, and the ability to bring in a diversity of talent from different parts of the world helps with innovation, learning from other countries and advancing our practices. This cross-fertilisation of knowledge is also critical within academia and research.
As the UK Government works to develop its future immigration system, it is important to remember that our members predominantly sponsor highly skilled individuals to facilitate:
Our members look to fill vaccines from within the UK in the first instance and we are committed to working with Government to maximise the number of resident workers filling roles across the industry.
We believe a future immigration system must be needs-based, straightforward and rapid, and one which facilitates the ease of movement for highly skilled talent in life sciences.
Want to find out what it’s like to work in the industry? Looking for opportunities to get into the industry, or the options available to you? Trying to advise someone interested in entering the industry? This section is here to help.
The ABPI offers qualifications in the ethical promotion of prescription medicines for industry representatives.
The UK is recognised worldwide as a leader in medical research and innovation, and the foundations for collaborations between industry and academia in the UK are exceptionally strong.
These examples showcase the variety of projects that have arisen over the last two years, from more traditional partnerships between one company and one institution, to pioneering consortia and novel patient biobanks.